期刊文献+

氟喹诺酮类药抗感染疗效影响因素分析 被引量:6

Analysis of Influencing Factors for Anti-infection Efficacy of Fluoroquinolones
原文传递
导出
摘要 目的:对影响氟喹诺酮类药抗感染疗效的影响因素进行分析,为该类药临床合理应用提供参考。方法:对132例使用氟喹诺酮类药治疗的患者制定抗感染疗效影响因素调查量表,并根据临床病例提供的数据填写,对包括年龄、性别、肝肾功能等在内的11个因素进行多因素Logistic回归分析,找出影响抗感染疗效的要因。结果:在氟喹诺酮类药疗效的影响因素中,年龄、性别、肌酐、丙氨酸氨基转移酶、天门冬酸氨基转移酶为影响该类药物抗菌效果的要因。结论:非老年患者、男性患者使用氟喹诺酮类药抗感染治疗效果更佳;肝肾功能异常患者使用时,应根据患者病情变化给予合适的剂量和给药间隔。 OBJECTIVE:To analyze the influencing factors of therapeutic efficacy of antibacterial fluoroquinolones,and to provide reference for rational use of fluoroquinolones in the clinic.METHODS:The scale of influencing factors for 132 patients who were treated with fluoroquinolones were designed and filled according to the data of clinical case,including age,gender,liver and renal function index,and other factors.The data were analyzed through Logistic regression analysis to determine the main factors that influenced therapeutic effects.RESULTS:Among influencing factors of therapeutic efficacy of fluoroquinolones,age,gender,Cr,ALT and AST were major factors.CONCLUSION:Fluoroquinolones is more effective in the treatment of bacterial infection in young population and male patients.Dosage and intervals of the drugs should be adjusted according to disease condition.
出处 《中国药房》 CAS CSCD 北大核心 2011年第30期2846-2848,共3页 China Pharmacy
关键词 氟喹诺酮类药 抗菌药物 影响因素 Fluoroquinolones Antibacterial Influencing factors
  • 相关文献

参考文献12

  • 1赵德恒,李娅杰,谢松梅,赵明,杨进波.对抗菌药物临床试验指导原则中疗效评价标准的考虑[J].中国临床药理学杂志,2008,24(6):564-565. 被引量:39
  • 2LaPlante KL, Rybak MJ, Tsuji B, et al. Fluoroquinolone Resistance in Streptococcus pneumoniae: Area Under the Concentration-Time Curve/MIC Ratio and Resistance Development with Gatifloxacin, Gemifloxacin, Levofloxacin, and Moxifloxacin[J]. Antimicrob Agents Chemother, 2007,51(4):1 315.
  • 3Stahlmann R, Lode H. Safety considerations of fluoroquinolones in the elderly: an update[J]. Drugs Aging, 2010, 27(3):193.
  • 4Wiseman LR, Balfour JA. Ciprofloxacin. A review of its pharmacological profile and therapeutic use in the elderly [J]. Drugs Aging, 1994,4( 2 ) : 145.
  • 5Zhang J, Xu Jf, Liu YB, et al. Population pharmacokinetics of oral levofloxacin 500 mg once-daily dosage in community-acquired lower respiratory tract infections: results of a prospective multicenter study in China[J].J Infect Chemother, 2009,15 (5) : 293.
  • 6王明霞,白颐卿,杜恩起.氟喹诺酮类药物在肾功能损害患者中的药物动力学[J].中国医院药学杂志,2000,20(5):291-294. 被引量:8
  • 7Bellmann R, Egger P, Gritsch W, etal. Elimination oflevofloxacin in critically ill patients with renal failure: influence of continuous veno-venous hemofiltration[J]. Int J Clin Pharmacol Ther, 2002.40 (4) : 142.
  • 8陈五波,林辉龙.肾功能减退时抗菌药物的应用[J].基层医学论坛,2009,13(7):247-248. 被引量:2
  • 9Ohtani H, Kinoshita Y, Nagasaki Y, et al. Dosage adjustment of quinolone antibiotics and angiotensin-converting enzyme inhibitors in patients with renal dysfunction[J]. Int J Clin Pharmacol Ther , 2006,44 (9) : 428.
  • 10Figueira-Coelho J, Pereira O, Picado B, et al. Acute hepatitis associated with the use of levofloxacin[J]. Clin Ther, 2010,32(10) : 1 733.

二级参考文献43

共引文献57

同被引文献33

  • 1段蕴铀.浅谈呼吸道感染中抗菌药物的临床应用[J].中国药物应用与监测,2005,2(1):17-19. 被引量:9
  • 2宋立新,魏春华.喹诺酮类药物与其它药物的相互作用[J].黑龙江医药,2006,19(3):211-213. 被引量:9
  • 3潘理平,谢学渊,张沂,王婷婷,郝纯.用DDDs分析住院药房抗生素药物的应用[J].解放军药学学报,2007,23(2):135-138. 被引量:14
  • 4李文全,贾玮.侵袭性真菌感染的研究进展[J].中国实用内科杂志,2007,27(17):1408-1410. 被引量:20
  • 5卫生部国家中医药管理局总后卫生部.抗菌药物临床应用指导原则[Z].卫医发[2004]285号.2004-08-19.
  • 6卫生部,国家中医药管理局,总后卫生部.抗菌药物临床应用指导原则[S],卫医发[2004]285号.2004,8.19.
  • 7卫生部国家中医药管理局总后卫生部.抗菌药物临床应用指导原则.2004-10-9.
  • 8国家药典委员会.2005年版中华人民共和国药典I临床用药须知.北京:人民卫生出版社,2005:457-573.
  • 9中华人民共和国卫生部,国家中医药管理局.总后卫生部抗菌药物临床应用指导原则.2004.285.
  • 10LaPlante KL, Rybak MJ, Tsuji B, et al. Fluoroquinolone Resistance in Streptococcus pneumoniae: Area Under the Concentration-Time Curve/ MIC Ratio and Resistance Development with Gatifloxacin, Gemifloxacin, Levofloxacin,and Moxifloxacin. Antimicrob Agents Chemother,2007,51 : 1315.

引证文献6

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部